Emerging sublingual immunotherapy drugs. - Wikidata - wikimedia - TriplyDB

Emerging sublingual immunotherapy drugs.

Emerging sublingual immunotherapy drugs.

http://www.wikidata.org/entity/Q37801372

about

A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2.

P2860

Q35980530-B077D626-B9AB-419E-80F1-0C2BF510A0FF Q39598878-C0390E5F-31D5-48A4-B1A1-8A5A33065656

P2860

Emerging sublingual immunotherapy drugs.

http://www.wikidata.org/entity/Q37801372

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging sublingual immunotherapy drugs.

@en

Emerging sublingual immunotherapy drugs.

@nl

type

label

Emerging sublingual immunotherapy drugs.

@en

Emerging sublingual immunotherapy drugs.

@nl

prefLabel

Emerging sublingual immunotherapy drugs.

@en

Emerging sublingual immunotherapy drugs.

@nl

P1433

Q37801372-384B898B-E324-4C10-B82F-6A1FD6B4AFDE

P1476

Q37801372-368DAAFF-90B1-4118-AB44-7E10A2D3E719

P2093

Q37801372-90E6EB1F-15A6-414B-8D95-DD3FE4EF2D02

Q37801372-C0E37C79-7C91-42DE-B82E-25B58AE038DD

P2860

Q37801372-00AC2846-C05C-409E-8F58-6F032693596F

Q37801372-01D82ED9-B9AA-4C51-B01F-0BA6EEC4CE9C

Q37801372-0C3A53A1-CFCD-4D52-8343-11DD05E4E643

Q37801372-0DDD38E4-24F0-4FDA-9D2F-654B5D23F88B

Q37801372-14635A14-8F7F-4752-BF64-5A72C5EF3486

Q37801372-19E111E8-0C73-40FF-AA1B-40B7F16DA6B9

Q37801372-20B77D05-881E-4ABF-A042-8AB423AF7D58

Q37801372-264062BC-0637-4DBC-8261-A26E1C2797E5

Q37801372-2C984B1A-21CF-4B78-9E59-353F64296516

Q37801372-36660F2F-D9FC-43C5-83FA-C2A2FF9201A4

P304

Q37801372-EA25E924-D42A-4961-9132-D2A06AA48A83

P31

Q37801372-DA29B641-C1A8-411C-BABA-38A3E7826F40

P356

Q37801372-335D6709-66C7-4EED-AB9E-468F90D340C2

P407

Q37801372-C1F5E59A-E5F2-43D5-8A6D-E93CD7749D5A

P433

Q37801372-DCAAEA38-085E-42E1-BB03-9DBFD47F1ABF

P478

Q37801372-7ABCBACD-7E5F-43D0-AFFE-7B2253132574

P50

Q37801372-812DB3F8-D046-4B51-8674-FC554DD2C3FB

Q37801372-B96CE21C-AE66-4C87-B14E-DCAD0EA9E893

Q37801372-C7FCCBE2-622F-488C-91A6-7C807D09C64E

P577

Q37801372-F18558C3-F83F-4B37-BAAB-E9ACCF9F8C78

P698

Q37801372-D4B8D94E-9F24-4D21-BDBC-42891605A685

P921

Q37801372-D71324A1-0F7C-4A4F-BDB3-6216DF6FA6E5

P356

14656566.2010.512420

P1433

Expert Opinion on Pharmacotherapy

P1476

Emerging sublingual immunotherapy drugs.

@en

P2093

Anthi Rogkakou

http://www.w3.org/2001/XMLSchema#string

Elisa Villa

http://www.w3.org/2001/XMLSchema#string

P2860

Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care

Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

Allergic rhinitis and its impact on asthma.

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.

Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.

Sublingual immunotherapy: a comprehensive review.

P304

2963-2972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2010.512420

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Giorgio Walter Canonica

Enrico Compalati

Giovanni Passalacqua

P577

2010-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20958111

http://www.w3.org/2001/XMLSchema#string

P921